Amgen acquires German drug
Story updated at 11 a.m.: Thousand Oaks-based biotech giant Amgen acquired global development rights to a multiple myeloma drug from a German company Sept. 1. Amgen said in a news release it acquired commercial and development rights to BI 836909, which is currently being developed by German company Boehringer Ingelheim. It will work with Boehringer Read More →
Read More →Semtech Q2 revenues soar
Semtech revenues increased along with profits and earnings per share during the second quarter of fiscal year 2017 the company announced Aug. 31. Semtech, a Camarillo-based manufacturer of semi-conductors for the smartphone industry, released quarterly earnings results Aug. 31. Revenues increased 8 percent from $125.7 million during the same quarter last year to $135.9 million Read More →
Read More →FDA approves biosimilar of Amgen’s Enbrel
The U.S. Food and Drug Administration formally approved a competing biosimilar of Amgen’s top-selling drug Enbrel on Aug. 30. Made by Switzerland-based Novartis, Erelzi mimics the effects of Enbrel. Enbrel, which was first approved in 1998, is approved to treat rheumatoid arthritis and other conditions by decreasing the amount of a protein produced by the Read More →
Read More →Interlink revenues, profits, earnings per share rise slightly
Interlink Electronics’ revenues increases slightly, profits increased slightly and earnings per share increased slightly during the second quarter, the company said Aug. 15 when it released second quarter earnings results. Based in Westlake Village, Interlink Electronics manufactures sensors used in portable electronic devices. Revenues increased 7 percent during the quarter from $2.8 million in 2015 Read More →
Read More →Clean Diesel second quarter revenues down but profits up
Revenues were down for Clean Diesel Technologies but the company still recorded increases in profits and earnings per share when the company released second quarter earnings Aug. 15. Clean Diesel revenues fell during the quarter from $9.9 million in 2015 to $8.4 million in 2016. Despite this, income increased from a net loss of $2.4 Read More →
Read More →